The resolution designates the last Tuesday of April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day in Alabama, aiming to raise awareness about this specific type of kidney disease and encourage research for improved treatments and potential cures. It highlights the genetic factors associated with AMKD, particularly the APOL1 gene mutations that significantly increase the risk of kidney disease among individuals of Western and Central African ancestry. The resolution emphasizes the disproportionate impact of kidney disease on African Americans, who represent a significant percentage of kidney failure cases in the United States.

Furthermore, the resolution calls for increased public awareness and education regarding AMKD, particularly for those at risk, to facilitate early diagnosis and management of the disease. It encourages individuals with APOL1 genetic variants to engage in proactive health measures, such as regular medical consultations and healthy lifestyle choices, to mitigate their risk of kidney failure. The resolution also acknowledges the lack of approved treatments for APOL1-mediated kidney disease but expresses hope for advancements through clinical trials. Overall, it seeks the cooperation of all Alabama citizens in supporting research efforts for effective treatments and a cure.